Suppr超能文献

登革2型病毒包膜蛋白结构域III上登革病毒复合体特异性中和表位的鉴定

Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus.

作者信息

Gromowski Gregory D, Barrett Nicholas D, Barrett Alan D T

机构信息

Department of Pathology, Sealy Center for Vaccine Development, Center for Biodefense and Emerging Infectious Diseases, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas 77555-0609, USA.

出版信息

J Virol. 2008 Sep;82(17):8828-37. doi: 10.1128/JVI.00606-08. Epub 2008 Jun 18.

Abstract

The surface of the mature dengue virus (DENV) particle is covered with 180 envelope (E) proteins arranged as homodimers that lie relatively flat on the virion surface. Each monomer consists of three domains (ED1, ED2, and ED3), of which ED3 contains the critical neutralization determinant(s). In this study, a large panel of DENV-2 recombinant ED3 mutant proteins was used to physically and biologically map the epitopes of five DENV complex-specific monoclonal antibodies (MAbs). All five MAbs recognized a single antigenic site that includes residues K310, I312, P332, L389, and W391. The DENV complex antigenic site was located on an upper lateral surface of ED3 that was distinct but overlapped with a previously described DENV-2 type-specific antigenic site on ED3. The DENV complex-specific MAbs required significantly higher occupancy levels of available ED3 binding sites on the virion, compared to DENV-2 type-specific MAbs, in order to neutralize virus infectivity. Additionally, there was a great deal of variability in the neutralization efficacy of the DENV complex-specific MAbs with representative strains of the four DENVs. Overall, the differences in physical binding and potency of neutralization observed between DENV complex- and type-specific MAbs in this study demonstrate the critical role of the DENV type-specific antibodies in the neutralization of virus infectivity.

摘要

成熟登革病毒(DENV)颗粒的表面覆盖着180个包膜(E)蛋白,这些蛋白以同二聚体形式排列,相对平躺在病毒体表面。每个单体由三个结构域(ED1、ED2和ED3)组成,其中ED3包含关键的中和决定簇。在本研究中,使用了大量DENV-2重组ED3突变蛋白对五种DENV复合物特异性单克隆抗体(MAb)的表位进行物理和生物学定位。所有五种MAb识别一个单一的抗原位点,该位点包括K310、I312、P332、L389和W391残基。DENV复合物抗原位点位于ED3的上侧面,该侧面与ED3上先前描述的DENV-2型特异性抗原位点不同但有重叠。与DENV-2型特异性MAb相比,DENV复合物特异性MAb需要病毒体上可用的ED3结合位点有显著更高的占据水平,才能中和病毒感染性。此外,DENV复合物特异性MAb对四种DENV代表性毒株的中和效力存在很大差异。总体而言,本研究中观察到的DENV复合物特异性MAb与型特异性MAb在物理结合和中和效力方面的差异,证明了DENV型特异性抗体在中和病毒感染性中的关键作用。

相似文献

3
A DENV-2-type-specific monoclonal antibody binds to the DENV-complex-reactive antigenic site on envelope protein domain 3.
J Gen Virol. 2017 Jun;98(6):1299-1304. doi: 10.1099/jgv.0.000785. Epub 2017 Jun 20.
4
Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
Virology. 2009 Feb 5;384(1):16-20. doi: 10.1016/j.virol.2008.11.013. Epub 2008 Dec 19.
5
Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III.
J Gen Virol. 2010 Sep;91(Pt 9):2249-53. doi: 10.1099/vir.0.021220-0. Epub 2010 May 5.
7
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.
Proc Natl Acad Sci U S A. 2012 May 8;109(19):7439-44. doi: 10.1073/pnas.1200566109. Epub 2012 Apr 12.
8
Genotype-specific neutralization and protection by antibodies against dengue virus type 3.
J Virol. 2010 Oct;84(20):10630-43. doi: 10.1128/JVI.01190-10. Epub 2010 Aug 11.

引用本文的文献

6
A stochastic B cell affinity maturation model to characterize mechanisms of protection for tetravalent dengue vaccine constructs.
Front Mol Biosci. 2023 Jul 14;10:1100434. doi: 10.3389/fmolb.2023.1100434. eCollection 2023.
8
Discovery of B-cell epitopes for development of dengue vaccines and antibody therapeutics.
Med Microbiol Immunol. 2022 Feb;211(1):1-18. doi: 10.1007/s00430-021-00726-1. Epub 2022 Jan 21.
10
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.
Front Cell Infect Microbiol. 2020 Oct 22;10:572681. doi: 10.3389/fcimb.2020.572681. eCollection 2020.

本文引用的文献

1
The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.
Cell Host Microbe. 2007 Apr 19;1(2):135-45. doi: 10.1016/j.chom.2007.03.002.
5
Probing the flavivirus membrane fusion mechanism by using monoclonal antibodies.
J Virol. 2007 Oct;81(20):11526-31. doi: 10.1128/JVI.01041-07. Epub 2007 Aug 1.
6
Solution structure of the envelope protein domain III of dengue-4 virus.
Virology. 2007 Jul 20;364(1):147-54. doi: 10.1016/j.virol.2007.02.023. Epub 2007 Mar 29.
7
The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry.
Microbes Infect. 2007 Jan;9(1):1-6. doi: 10.1016/j.micinf.2006.09.009. Epub 2006 Dec 6.
8
Flavivirus membrane fusion.
J Gen Virol. 2006 Oct;87(Pt 10):2755-2766. doi: 10.1099/vir.0.82210-0.
9
Structural basis of West Nile virus neutralization by a therapeutic antibody.
Nature. 2005 Sep 29;437(7059):764-9. doi: 10.1038/nature03956.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验